Trial Profile
Study on glycemic control, weight, body fat and insulin resistance in SGLT2 inhibitor-treated Japanese patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2020
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SGLT2 Study
- 30 Jun 2017 Status changed from recruiting to completed.
- 04 Mar 2015 New trial record